ACADVL Antikörper (C-Term)
Kurzübersicht für ACADVL Antikörper (C-Term) (ABIN928726)
Target
Alle ACADVL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Aufreinigung
- Purified
-
Immunogen
- ACADVL antibody was raised in rabbit using the C terminal of ACADVL as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
ACADVL Blocking Peptide, catalog no. 33R-3923, is also available for use as a blocking control in assays to test for specificity of this ACADVL antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- ACADVL (Acyl-CoA Dehydrogenase, Very Long Chain (ACADVL))
-
Andere Bezeichnung
- ACADVL
-
Hintergrund
- ACADVL is targeted to the inner mitochondrial membrane where it catalyzes the first step of the mitochondrial fatty acid beta-oxidation pathway. This acyl-Coenzyme A dehydrogenase is specific to long-chain and very-long-chain fatty acids. A deficiency in ACADVL protein reduces myocardial fatty acid beta-oxidation and is associated with cardiomyopathy. Synonyms: Polyclonal ACADVL antibody, Anti-ACADVL antibody, acyl-Coenzyme A dehydrogenase, very long chain antibody, ACAD6 antibody, LCACD antibody, VLCAD antibody.
-
Pathways
- ER-Nucleus Signaling, Monocarboxylic Acid Catabolic Process
Target
-